Business
Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates
Proprietary robotically-navigated MAGiC catheter received U.S. FDA approval in January and is now being utilized at multiple sites across the United States as well as EuropeSynchrony digital operating room system received U.S. FDA clearance in April and initial orders and shipments are ongoingDefinitive agreement to acquire Robocath creates a leading robotic platform, combining complementary technologies to deliver next-generation fully-integrated robotic solutions for the full spectrum of endov
About this update from Stereotaxis, Inc.
[{"type":"image","alt":"Stereotaxis, Inc.","displaySize":"","headline":null,"caption":"Stereotaxis, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":102,"url":"https://media.zenfs.com/en/globenewswire.com/7fe59cbbf6bc2c2a861b379e08e5c6ad"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/9SBwn9GekjRHtp_pM0a4QA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0MztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/7fe59cbbf6bc2c2a861b379e08e5c6ad","width":300,"height":102},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/9SBwn9GekjRHtp_pM0a4QA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0MztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/7fe59cbbf6bc2c2a861b379e08e5c6ad","width":300,"height":102}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Proprietary robotically-navigated MAGiC catheter received U.S. FDA approval in January and is now being utilized at multiple sites across the United States as well as Europe","length":173,"tagName":"p"}]},{"val":[{"type":"text","content":"Synchrony digital operating room system received U.S. FDA clearance in April and initial orders and shipments are ongoing","length":121,"tagName":"p"}]},{"val":[{"type":"text","content":"Definitive agreement to acquire Robocath creates a leading robotic platform, combining complementary technologies to deliver next-generation fully-integrated robotic solutions for the full spectrum of endovascular procedures","length":224,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":518,"olType":false},{"type":"text","content":"ST. LOUIS, May 12, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported business updates and financial results for the first quarter ended March 31, 2026.","length":266,"tagName":"p"},{"type":"text","content":"“Stereotaxis is in one of the most exciting periods of its history. We are achieving significant regulatory approvals, executing strategic acquisitions, and witnessing the initial green shoots of commercial success with our new product ecosystem,” said David Fischel, Stereotaxis Chairman and CEO. “The operational and commercial friction to ramp up manufacturing and implement new products makes progress gradual, but we are efficiently driving broad-based progress on many fronts in...